Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell-like Properties in Cancer CellsSHIEN, Kazuhiko; TOYOOKA, Shinichi; TSUKUDA, Kazunori et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 10, pp 3051-3061, issn 0008-5472, 11 p.Article

EGFR Antagonists in Cancer TreatmentCIARDIELLO, Fortunato; TORTORA, Giampaolo.The New England journal of medicine. 2008, Vol 358, Num 11, pp 1160-1174, issn 0028-4793, 15 p.Article

Bioimpact of EGFR antagonists on the pilosebaceous folliclesPIERARD, Gerald E; PIERARD-FRANCHIMONT, Claudine; HUMBERT, Philippe et al.EJD. European journal of dermatology. 2012, Vol 22, Num 1, pp 54-57, issn 1167-1122, 4 p.Article

Syndrome mains-pieds : nouvel effet secondaire de l'erlotinib = Hand-foot syndrome : A new side effect of erlotinibROUXEL, A.-M; ROGUEDAS, A.-M; DESCOURT, R et al.Annales de dermatologie et de vénéréologie. 2008, Vol 135, Num 11, pp 762-764, issn 0151-9638, 3 p.Article

Sym004: A Novel Synergistic Anti-Epidermal Growth Factor Receptor Antibody Mixture with Superior Anticancer EfficacyPEDERSEN, Mikkel Wandahl; JACOBSEN, Helle Jane; KOEFOED, Klaus et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 2, pp 588-597, issn 0008-5472, 10 p.Article

Emerging role of epidermal growth factor receptor inhibition in therapy for advanced malignancy: Focus on NSCLCLANGER, Corey J.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 3, pp 991-1002, issn 0360-3016, 12 p.Conference Paper

Targeting Stat3 Abrogates EGFR Inhibitor Resistance in CancerSEN, Malabika; JOYCE, Sonali; PANAHANDEH, Mary et al.Clinical cancer research (Print). 2012, Vol 18, Num 18, pp 4986-4996, issn 1078-0432, 11 p.Article

Effets cutanés des nouvelles molécules utilisées en cancérologie = New drugs in oncology and skin toxicityMATEUS, C; ROBERT, C.La Revue de médecine interne (Paris). 2009, Vol 30, Num 5, pp 401-410, issn 0248-8663, 10 p.Article

The TGFβ―miR200―MIG6 Pathway Orchestrates the EMT-Associated Kinase Switch That Induces Resistance to EGFR InhibitorsIZUMCHENKO, Evgeny; XIAOFEI CHANG; SIDRANSKY, David et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 14, pp 3995-4005, issn 0008-5472, 11 p.Article

VECTIBIX^® (panitumumab, Amgen) Anticorps anti-EGFRRANCIERE, Fanny; DEBRIX, Isabelle; SELLE, Frédéric et al.Onko +. 2011, Vol 3, Num 23, pp 149-151, issn 2101-9495, 3 p.Article

Design and synthesis of 4,6-substituted-(diaphenylamino)quinazolines as potent EGFR inhibitors with antitumor activityLI, Huan-Qiu; LI, Dong-Dong; XIANG LU et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 1, pp 317-323, issn 0968-0896, 7 p.Article

Incapacité motrice et fasciite radiologique sous erlotinib = Functional impairment and radiologic fasciitis under erlotinib therapyOSDOIT, S; WIERZBICKA, E; GUILLET, G et al.Annales de dermatologie et de vénéréologie. 2011, Vol 138, Num 6-7, pp 494-498, issn 0151-9638, 5 p.Article

Discovery of novel selective inhibitors for EGFR-T790M/L858RFANG BAI; HONGYAN LIU; HONGLIN LI et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 3, pp 1365-1370, issn 0960-894X, 6 p.Article

MECHANISMS OF RESISTANCE TO EGFR INHIBITORS IN HEAD AND NECK CANCERCOOPER, Jonathan B; EDDY WYSSAM COHEN, Ezra.Head & neck. 2009, Vol 31, Num 8, pp 1086-1094, issn 1043-3074, 9 p.Article

Nouveaux antiangiogéniques: état de la recherche : Antiangiogéniques et cancer colorectal métastatique = Update on novel antiangiogenic compoundsJOUINOT, Anne; DREYER, Chantal; BOUATTOUR, Mohamed et al.Cancéro digest. 2010, Vol 2, Num 3, pp 199-204, issn 1953-5171, 6 p.Article

Anti-epidermal growth factor receptor therapy for advanced head and neck squamous cell carcinoma: a meta-analysisSHOUDE ZHANG; JIA CHEN; HUA JIANG et al.European journal of clinical pharmacology. 2012, Vol 68, Num 5, pp 561-569, issn 0031-6970, 9 p.Article

Interdisciplinary management of EGFR-inhibitor- induced skin reactions: a German expert opinionPOTTHOFF, K; HOFHEINZ, R; TRARBACH, T et al.Annals of oncology. 2011, Vol 22, Num 3, pp 524-535, issn 0923-7534, 12 p.Article

Reprint of Nanobody — Shell functionalized thermosensitive core-crosslinked polymeric micelles for active drug targetingTALELLI, Marina; RIJCKEN, Cristianne J. F; OLIVEIRA, Sabrina et al.Journal of controlled release. 2011, Vol 153, Num 1, pp 93-102, issn 0168-3659, 10 p.Conference Paper

EGFR blockade with ZD1839 (IRESSA) potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinomaSOLOMON, Benjamin; HAGEKYRIAKOU, Jim; TRIVETT, Melanie K et al.International journal of radiation oncology, biology, physics. 2003, Vol 55, Num 3, pp 713-723, issn 0360-3016, 11 p.Article

Significant increase in hEGF uptake is correlated with formation of EGFR dimers induced by the EGFR tyrosine kinase inhibitor gefitinibPENG HE; GANG LI.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 2, pp 341-348, issn 0344-5704, 8 p.Article

Design and synthesis of pyrrolo[3,2-d]pyrimidine HER2/EGFR dual inhibitors: Improvement of the physicochemical and pharmacokinetic profiles for potent in vivo anti-tumor efficacyKAWAKITA, Youichi; MIWA, Kazuhiro; TANAKA, Toshimasa et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 20, pp 6171-6180, issn 0968-0896, 10 p.Article

Nanobody — Shell functionalized thermosensitive core-crosslinked polymeric micelles for active drug targetingTALELLI, Marina; RIJCKEN, Cristianne J. F; OLIVEIRA, Sabrina et al.Journal of controlled release. 2011, Vol 151, Num 2, pp 183-192, issn 0168-3659, 10 p.Article

SEQUENCE DEPENDENCE OF CELL GROWTH INHIBITION BY EGFR-TYROSINE KINASE INHIBITOR ZD1839, DOCETAXEL, AND CISPLATIN IN HEAD AND NECK CANCERKLASS, Carmen M; MI SUN CHOE; HURWITZ, Selwyn J et al.Head & neck. 2009, Vol 31, Num 10, pp 1263-1273, issn 1043-3074, 11 p.Article

Prise en charge des toxicités cutanées des thérapies dirigées contre les récepteurs du facteur de croissance épidermique : revue de la littérature = Management of cutaneous toxicities induced by epidermal growth factor receptor inhibitors : a reviewMESTDAGH, K; FINK, W; HENDLISZ, A et al.Revue médicale de Bruxelles. 2008, Vol 29, Num 6, pp 552-558, issn 0035-3639, 7 p.Article

Antitumor Activity of Taspine by Modulating the EGFR Signaling Pathway of Erk1/2 and Akt In Vitro and In VivoYANMIN ZHANG; LEI ZHENG; JIE ZHANG et al.Planta medica. 2011, Vol 77, Num 16, pp 1774-1781, issn 0032-0943, 8 p.Article